title: Quality Indicators and Outcomes of Emergency Caesarean Deliveries at a District-level Maternity Hospital.
abstract: The objective of this research study is to identify quality indicators of cesarean deliveries and determine their relationship to neonatal and maternal morbidity and mortality in one high volume maternity hospital in Lilongwe, Malawi. Demographic, perioperative, and postoperative data were collected on all cesarean deliveries over three months. Indicators of quality (antibiotic administration, use of oxytocin, decision-to-incision time, and uterine incision type) were compared to maternal morbidities (postpartum hemorrhage, fistula and wound infection) and neonatal mortality. Causes of delays in decision to incision time were identified. 513 cesarean deliveries were performed during the study period, with no maternal deaths and 39 neonatal deaths. Adherence to oxytocin and antibiotic administration was high but not complete, with greater adherence to the former (97.1% vs 82.6%). The decision to incision time between women with and without neonatal deaths was similar (1.62 hours vs 1.49 hours, p = 0.41). Most delays were attributed to a busy operating theatre (49.1%) and delayed transfer to the operating theatre (26.9%). Uterine rupture and cesarean hysterectomy were associated with an outcome of neonatal death (p < 0.001). Infrastructure and personnel limitations are major barriers to the improvement of quality of cesarean deliveries. Future endeavors towards quality improvement must address these deficiencies.
authors.forename: Melike
authors.initials: M
authors.lastname: Harfouche
authors.forename: Mina
authors.initials: M
authors.lastname: Hosseinipour
authors.forename: Stephen
authors.initials: S
authors.lastname: Kaliti
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Wilkinson
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002585:Cesarean Section / Q000592:standards*; D015331:Cohort Studies; D004630:Emergencies; D005260:Female; D006767:Hospitals, District / Q000592:standards*; D061847:Hospitals, High-Volume; D006771:Hospitals, Maternity / Q000592:standards*; D006801:Humans; D007223:Infant; D007226:Infant Mortality; D007231:Infant, Newborn; D008295:Malawi; D017063:Outcome Assessment, Health Care; D010120:Oxytocics / Q000627:therapeutic use; D010121:Oxytocin / Q000627:therapeutic use; D006473:Postpartum Hemorrhage / Q000453:epidemiology / Q000517:prevention & control; D011247:Pregnancy; D011446:Prospective Studies; D019984:Quality Indicators, Health Care; D013530:Surgical Wound Infection / Q000453:epidemiology / Q000517:prevention & control; D061665:Time-to-Treatment / Q000706:statistics & numerical data; D014597:Uterine Rupture / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D010120:Oxytocics; D010121:Oxytocin